Speaker Profile
PMWC PIONEER AWARD
Founded Epic, building the EHR backbone for data-driven care
Founder and CEO, Epic
Biography
Judy Faulkner, founder and CEO of Epic Systems, has significantly impacted precision medicine by pioneering the integration of genomic data into electronic health records, notably through Epics Aura platform, which enables tailored treatment strategies based on individual genetic profiles. Under her leadership, the Cosmos initiative has facilitated the aggregation of extensive de-identified patient data, substantially advancing clinical research and informed medical decision-making. Additionally, by embedding advanced AI technologies into Epic's systems, she has streamlined clinical workflows, aiding healthcare providers in documentation and patient communication. Epics extensive global presence, managing hundreds of millions of patient records, reflects Faulkner's profound influence on the healthcare landscape, further highlighted by her philanthropic commitment to reducing health disparities and improving healthcare accessibility.
Session Abstract – PMWC 2026 Silicon Valley
Track Chair:
Catriona Jamieson, UCSD
Opening talk
• Catriona Jamieson, UCSD
PMWC Award Ceremony
• Judy Faulkner, Epic
• Alexis C. Komor, UCSD
What’s Next at Epic?
• Peter DeVault, Epic
Modified mRNA, siRNA, ASOs
• Chair: Alexis C. Komor, UCSD
• Niren Murthy, UC Berkeley
• Gene Yeo, UCSD
• Reuben Harris, UT Health San Antonio
Stem Cell-Targeted Therapeutics: Small Molecules & Biologics
• Chair: Catriona Jamieson, UCSD
• Irving L. Weissman, Stanford
Space-Omics & Stem-Cell Adaptation
• Chair: Catriona Jamieson, UCSD
• Alysson Muotri, UCSD
In Vivo Gene Therapies
• Chair: Gene Yeo, UCSD
• Mark A Kay, Stanford
• David Schaffer, Berkeley
Diagnostics, Prognostics, and Patient Stratification
• Chair: Ezra Cohen, Tempus
• Eitan Ruppin, NIH
• David Ledbetter, Florida State University
• Ludmil Alexandrov, UCSD
Bioprinting Transplantable Liver: mRNA-Driven Multi-Lineage Differentiation from Autologous iPSCs
• Jiwu Wang, The Scintillon Institute
A New Era in Heart Failure Treatment: Delivering on the Promise of iPSC-Derived Cardiomyocyte Therapy
• Eugene Wang, Help Therapeutics
Closing Talk
• Catriona Jamieson, UCSD
